353 related articles for article (PubMed ID: 22000655)
1. Uric acid and transplantation.
Mazali FC; Mazzali M
Semin Nephrol; 2011 Sep; 31(5):466-71. PubMed ID: 22000655
[TBL] [Abstract][Full Text] [Related]
2. Uric acid and transplantation.
Mazzali M
Semin Nephrol; 2005 Jan; 25(1):50-5. PubMed ID: 15660335
[TBL] [Abstract][Full Text] [Related]
3. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.
Karbowska A; Boratynska M; Kusztal M; Klinger M
Transplant Proc; 2009 Oct; 41(8):3052-5. PubMed ID: 19857674
[TBL] [Abstract][Full Text] [Related]
4. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.
Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV
Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747
[TBL] [Abstract][Full Text] [Related]
5. Is uric acid a predictive factor for graft dysfunction in renal transplant recipients?
Akgul A; Bilgic A; Ibis A; Ozdemir FN; Arat Z; Haberal M
Transplant Proc; 2007 May; 39(4):1023-6. PubMed ID: 17524881
[TBL] [Abstract][Full Text] [Related]
6. Elderly renal transplant recipients and renal dysfunction: a risk factor for hyperuricemia.
Einollahi B; Einollahi H; Rostami Z
Exp Clin Transplant; 2011 Dec; 9(6):376-80. PubMed ID: 22142044
[TBL] [Abstract][Full Text] [Related]
7. Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy.
Akalin E; Ganeshan SV; Winston J; Muntner P
Transplantation; 2008 Sep; 86(5):652-8. PubMed ID: 18791445
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M
Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of early-onset hyperuricemia in renal transplant recipients.
Chung BH; Kang SH; Hwang HS; Choi BS; Park CW; Kim YS; Kim JI; Moon IS; Yang CW
Nephron Clin Pract; 2011; 117(3):c276-83. PubMed ID: 20847570
[TBL] [Abstract][Full Text] [Related]
10. Uric acid and chronic kidney disease: new understanding of an old problem.
Kang DH; Chen W
Semin Nephrol; 2011 Sep; 31(5):447-52. PubMed ID: 22000652
[TBL] [Abstract][Full Text] [Related]
11. Hyperuricemia after liver transplantation in children.
Harambat J; Dubourg L; Ranchin B; Hadj-Aïssa A; Fargue S; Rivet C; Boillot O; Lachaux A; Cochat P
Pediatr Transplant; 2008 Dec; 12(8):847-53. PubMed ID: 18537903
[TBL] [Abstract][Full Text] [Related]
12. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients.
Kanbay M; Akcay A; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
Transplant Proc; 2005 Sep; 37(7):3119-20. PubMed ID: 16213325
[TBL] [Abstract][Full Text] [Related]
13. Effects of hyperuricemia on renal function in pediatric renal transplant recipients.
Fidan C; Kantar A; Baskın E; Gülleroğlu K; Akdur A; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():247-50. PubMed ID: 25894164
[TBL] [Abstract][Full Text] [Related]
14. Role of uric acid in post-renal transplantation hypertension.
Bandukwala F; Huang M; Prasad GV
Transplant Proc; 2009 Jun; 41(5):1634-6. PubMed ID: 19545696
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
[TBL] [Abstract][Full Text] [Related]
16. Gout in renal allograft recipients according to the pretransplant hyperuricemic status.
Hernández-Molina G; Cachafeiro-Vilar A; Villa AR; Alberú J; Rull-Gabayet M
Transplantation; 2008 Dec; 86(11):1543-7. PubMed ID: 19077887
[TBL] [Abstract][Full Text] [Related]
17. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
[TBL] [Abstract][Full Text] [Related]
18. Uric acid: role in cardiovascular disease and effects of losartan.
Alderman M; Aiyer KJ
Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors of Hyperuricemia After Renal Transplantation and Its Long-term Effects on Graft Functions.
Eyupoglu S; Eyupoglu D; Kendi-Celebi Z; Akturk S; Tuzuner A; Keven K; Sengul S
Transplant Proc; 2017 Apr; 49(3):505-508. PubMed ID: 28340822
[TBL] [Abstract][Full Text] [Related]
20. Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival.
Numakura K; Satoh S; Tsuchiya N; Saito M; Maita S; Obara T; Tsuruta H; Inoue T; Narita S; Horikawa Y; Kagaya H; Miura M; Habuchi T
Transplantation; 2012 Jul; 94(2):145-51. PubMed ID: 22728291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]